Corteva, Inc. (CTVA)
| Market Cap | 58.02B +14.7% |
| Revenue (ttm) | 17.89B +6.3% |
| Net Income | 1.16B +1.9% |
| EPS | 1.71 +3.5% |
| Shares Out | 668.82M |
| PE Ratio | 47.17 |
| Forward PE | 23.46 |
| Dividend | $0.72 (0.83%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 3,138,180 |
| Open | 86.90 |
| Previous Close | 86.39 |
| Day's Range | 86.10 - 87.69 |
| 52-Week Range | 60.54 - 87.69 |
| Beta | 0.56 |
| Analysts | Buy |
| Price Target | 90.14 (+3.91%) |
| Earnings Date | Jul 30, 2026 |
About CTVA
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profit... [Read more]
Financial Performance
In 2025, Corteva's revenue was $17.40 billion, an increase of 2.92% compared to the previous year's $16.91 billion. Earnings were $1.09 billion, an increase of 20.62%.
Financial StatementsAnalyst Summary
According to 22 analysts, the average rating for CTVA stock is "Buy." The 12-month stock price target is $90.14, which is an increase of 3.91% from the latest price.
News
Corteva and Arevo Partner on Soy Crop Nutrition
The partnership will help farmers in Europe improve nutrient use efficiency The partnership will help farmers in Europe improve nutrient use efficiency
Corteva price target raised to $96 from $94 at Mizuho
Mizuho raised the firm’s price target on Corteva (CTVA) to $96 from $94 and keeps an Outperform rating on the shares following a review of the company’s SEC filing for…
Corteva Announces Board of Directors for Future Crop Protection Company
Greg Page to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today its intended board of directors as a standalone publicly-tr...
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
Karen Grimes to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future public...
Corteva Transcript: Wolfe Research 3rd Annual Materials of the Future Conference 2026
EU approval of gene editing marks a major regulatory shift, enabling new crop technologies and global market expansion. Proprietary innovation, AI-driven breeding, and hybrid wheat are set to drive growth, while the spin-off structure enhances strategic focus and financial performance.
FMC, Corteva announce co-exclusive rimisoxafen supply and license pact
FMC (FMC) and Corteva (CTVA) announced a co-exclusive strategic supply and license agreement that will expand access to FMC’s rimisoxafen technology across North and South America corn and soybean mar...
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
Strategic supply and license agreement will accelerate access for North and South American corn and soybean growers PHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE: ...
Corteva to cease production activities at site in Asturias, Spain
In a regulatory filing, the company said, “Corteva (CTVA) has been executing a multi-year footprint optimization and productivity initiative designed to enhance efficiency and reduce structural costs ...
Corteva price target raised to $91 from $84 at Barclays
Barclays analyst Benjamin Theurer raised the firm’s price target on Corteva (CTVA) to $91 from $84 and keeps an Overweight rating on the shares. The firm updated its valuation assumptions…
Corteva to Participate in Wolfe's Materials of the Future Conference
INDIANAPOLIS, June 10, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Financial Officer, David Johnson, and Chief Technology and Digital Officer, Sam Eathington, will speak at Wo...
Corteva price target lowered to $86 from $90 at UBS
UBS analyst Joshua Spector lowered the firm’s price target on Corteva (CTVA) to $86 from $90 and keeps a Neutral rating on the shares.
Corteva price target raised to $95 from $84 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews raised the firm’s price target on Corteva (CTVA) to $95 from $84 and keeps an Overweight rating on the shares. The market is valuing “New…
Corteva Announces Dates for Second Quarter 2026 Earnings Release and Webcast
INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its second quarter 2026 earnings on Thursday, July 30, 2026, after the stock market close via pres...
Corteva Transcript: 21st Annual Global Farm to Market Conference
Strong Q1 growth and robust global demand set a positive tone ahead of the planned Q4 separation into focused seed and crop protection entities. Strategic investments in gene editing, hybrid wheat, and licensing are expected to drive significant long-term growth, while both new companies will maintain strong balance sheets and pursue innovation-led strategies.
Corteva headquarters its new companies in Indiana and Iowa
Corteva (CTVA) announced that “New Corteva,” its future crop protection company, will be headquartered in Indianapolis, Indiana, and Vylor, its advanced seed and genetics company, will be headquartere...
Corteva Announces Headquarters for Two Future Companies Following Planned Separation
Indianapolis, Indiana and Johnston, Iowa Chosen INDIANAPOLIS and JOHNSTON, Iowa, May 12, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today that "New Corteva," its future crop protection c...
Corteva to Participate in BMO Global Farm to Market Conference
INDIANAPOLIS, May 7, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Executive Officer Chuck Magro and Executive Vice President and Chief Financial Officer David Johnson will spea...
Corteva price target raised to $90 from $88 at UBS
UBS analyst Joshua Spector raised the firm’s price target on Corteva (CTVA) to $90 from $88 and keeps a Neutral rating on the shares.
Corteva price target raised to $90 from $87 at BofA
BofA raised the firm’s price target on Corteva (CTVA) to $90 from $87 and keeps a Buy rating on the shares. Q1 adjusted EPS of $1.50 was “well ahead” of…
Corteva price target raised to $85 from $83 at Citi
Citi raised the firm’s price target on Corteva (CTVA) to $85 from $83 and keeps a Neutral rating on the shares.
Corteva Earnings Call Transcript: Q1 2026
Q1 2026 saw 21% EBITDA growth and margin expansion, driven by strong Seed and Crop Protection performance. Full-year guidance is reaffirmed, with continued organic growth, cost productivity, and progress on the planned separation into two companies.
Corteva Earnings release: Q1 2026
Corteva released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Corteva Slides: Q1 2026
Corteva has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Corteva Quarterly report: Q1 2026
Corteva has published its Q1 2026 quarterly earnings report on May 6, 2026.
Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
First quarter sales reflect strength of Seed and Crop Protection technology portfolios and progress on growth platforms Continued productivity and cost initiatives across both businesses further impro...